Gastric Neuroendocrine Tumors With Parietal Cell Atrophy in a Long-term Carcinogenicity Study in Rats.

Norimitsu Shirai1, Shambhunath Choudhary2, Christopher Houle1

  • 1Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut, USA.

Summary

High doses of a novel cannabinoid-1 antagonist induced stomach neuroendocrine tumors in rats. This was linked to parietal cell atrophy and altered gastric acid secretion, a rare occurrence in rats.